Oryzon Genomics (Spain) Market Value
| ORY Stock | EUR 2.87 0.03 1.06% |
| Symbol | Oryzon |
Oryzon Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oryzon Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oryzon Genomics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Oryzon Genomics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Oryzon Genomics SA or generate 0.0% return on investment in Oryzon Genomics over 90 days. Oryzon Genomics is related to or competes with Media Investment, Parlem Telecom, Atrys Health, Bankinter, Elaia Investment, Atom Hoteles, and Atresmedia Corporacin. Oryzon Genomics S.A., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies to treat o... More
Oryzon Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oryzon Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oryzon Genomics SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.48 | |||
| Information Ratio | 0.1816 | |||
| Maximum Drawdown | 45.3 | |||
| Value At Risk | (4.22) | |||
| Potential Upside | 9.34 |
Oryzon Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oryzon Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oryzon Genomics' standard deviation. In reality, there are many statistical measures that can use Oryzon Genomics historical prices to predict the future Oryzon Genomics' volatility.| Risk Adjusted Performance | 0.153 | |||
| Jensen Alpha | 0.955 | |||
| Total Risk Alpha | 1.82 | |||
| Sortino Ratio | 0.2085 | |||
| Treynor Ratio | (1.42) |
Oryzon Genomics SA Backtested Returns
Oryzon Genomics is dangerous given 3 months investment horizon. Oryzon Genomics SA maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.04% are justified by taking the suggested risk. Use Oryzon Genomics Coefficient Of Variation of 602.96, semi deviation of 4.11, and Risk Adjusted Performance of 0.153 to evaluate company specific risk that cannot be diversified away. Oryzon Genomics holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of -0.73, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Oryzon Genomics are expected to decrease at a much lower rate. During the bear market, Oryzon Genomics is likely to outperform the market. Use Oryzon Genomics potential upside, accumulation distribution, price action indicator, as well as the relationship between the expected short fall and day median price , to analyze future returns on Oryzon Genomics.
Auto-correlation | -0.54 |
Good reverse predictability
Oryzon Genomics SA has good reverse predictability. Overlapping area represents the amount of predictability between Oryzon Genomics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oryzon Genomics SA price movement. The serial correlation of -0.54 indicates that about 54.0% of current Oryzon Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.43 |
Oryzon Genomics SA lagged returns against current returns
Autocorrelation, which is Oryzon Genomics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oryzon Genomics' stock expected returns. We can calculate the autocorrelation of Oryzon Genomics returns to help us make a trade decision. For example, suppose you find that Oryzon Genomics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oryzon Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oryzon Genomics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oryzon Genomics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oryzon Genomics stock over time.
Current vs Lagged Prices |
| Timeline |
Oryzon Genomics Lagged Returns
When evaluating Oryzon Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oryzon Genomics stock have on its future price. Oryzon Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oryzon Genomics autocorrelation shows the relationship between Oryzon Genomics stock current value and its past values and can show if there is a momentum factor associated with investing in Oryzon Genomics SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Oryzon Stock
Oryzon Genomics financial ratios help investors to determine whether Oryzon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oryzon with respect to the benefits of owning Oryzon Genomics security.